Atherion Bioresearch

Atherion Bioresearch is a US-based clinical research organization established by industry veterans to address perceived gaps in traditional CRO partnerships. The company leverages its team's extensive sponsor-side experience, particularly in radiopharmaceuticals and complex therapeutic areas, to serve as a true development partner for biotech and pharmaceutical clients. Its core mission centers on integrity, innovation, and collaboration to advance life-changing therapies efficiently from early development through late-stage trials.

Atherion does not own a proprietary technology platform. Its core offering is deep domain expertise and specialized service capabilities in clinical development, operations, and regulatory affairs, with a particular focus on radiopharmaceuticals, radiotherapeutics, and innovative trial design.

Total raised: $2.5M

Atherion competes against large global CROs (e.g., IQVIA, ICON) and other specialty CROs. Its main differentiation is deep, sponsor-side expertise in the complex niche of radiopharmaceuticals and radiotherapeutics, a collaborative partner-led model, and a leadership team with proven track records in advancing compounds themselves. It positions itself as an agile, expert alternative to larger, less specialized providers.